GlobeImmune (United States)
GlobeImmune, Inc. is a clinical-stage public biopharmaceutical company headquartered in Louisville, Colorado, that develops therapeutic vaccines to treat cancer and infectious diseases. As of August 2014, the company had no marketed products. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for GlobeImmune (United States), United States, covering academic research published from 2002 to 2020. Read More.
Open Access Percentage
35%
Total
Publications
55
Total Open
Publications
19
Total
Citations
3.3K
Open Access
Percentage
35%
Total
Publications
55
Total Open
Publications
19
Total
Citations
3.3K
Breakdown
Publisher Open
12%
Both
21%
Other Platform Open
4%
Closed
63%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 42%
8
Hybrid 21%
4
No Guarantees 37%
7
Other Platform Open
Domain 50%
7
Other Internet 50%
7
Institution 21%
3
Public 7%
1
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 7 |
DOI | Other Internet | 7 |
Yonsei University | Institution | 1 |
University of Modena and Reggio Emilia | Institution | 1 |
Royal Netherlands Academy of Arts and Sciences | Institution | 1 |
nus.edu.sg OAI-PMH Repository | Institution | 1 |
Figshare | Public | 1 |
Erasmus University Rotterdam | Institution | 1 |